U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06823895) titled 'Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules' on Dec. 15, 2024.
Brief Summary: The objective of this clinical trial is to learn the sequence and expression level of Maixuekang oligonucleotides in the plasma of healthy volunteers.
1. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after a single administration of Maixuekang at different time points.
2. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after multiple administrations of Maixuekang at different time points.
Single dose group: Par...